Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Endocrine journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1507/ENDOCRJ.K08E-228PMID 18753704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological roles of lysophospholipid receptors revealed by genetic null mice: an update.

  2008cited by this paper
• Plasma sphingosine 1-phosphate metabolism and analysis.

  2008influential reference
• HDL-Associated Lysosphingolipids Inhibit NAD(P)H Oxidase–Dependent Monocyte Chemoattractant Protein-1 Production

  2008cited by this paper
• Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system.

  2008cited by this paper
• Sphingosine-1-Phosphate Receptor Subtypes Differentially Regulate Smooth Muscle Cell Phenotype

  2008cited by this paper
• S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN.

  2008cited by this paper
• Analysis of sphingosine 1‐phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools

  2008cited by this paper
• Long Pentraxin 3, a Key Component of Innate Immunity, Is Modulated by High-Density Lipoproteins in Endothelial Cells

  2008cited by this paper
• G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase.

  2008cited by this paper
• Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate

  2008cited by this paper
• The Scavenger Receptor Class B Type I Adaptor Protein PDZK1 Maintains Endothelial Monolayer Integrity

  2008cited by this paper
• Sphingosine 1-phosphate induces platelet/endothelial cell adhesion molecule-1 phosphorylation in human endothelial cells through cSrc and Fyn.

  2008influential reference
• High Density Lipoprotein-associated Sphingosine 1-Phosphate Promotes Endothelial Barrier Function*

  2008cited by this paper
• Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles: Relevance to Antiapoptotic and Antioxidative Activities

  2007cited by this paper
• HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects Published, JLR Papers in Press, August 13, 2007.

  2007cited by this paper
• Reconstituted High-Density Lipoprotein Stimulates Differentiation of Endothelial Progenitor Cells and Enhances Ischemia-Induced Angiogenesis

  2007cited by this paper
• Agonist-modulated Regulation of AMP-activated Protein Kinase (AMPK) in Endothelial Cells

  2007influential reference
• Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes.

  2007cited by this paper
• Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina.

  2007cited by this paper
• High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis.

  2007cited by this paper
• Sphingosine 1-Phosphate Receptor 2 Negatively Regulates Neointimal Formation in Mouse Arteries

  2007cited by this paper
• Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate

  2007cited by this paper
• HDL and its sphingosine-1-phosphate content in cardioprotection

  2007cited by this paper
• Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cells.

  2007influential reference
• Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.

  2007cited by this paper
• Induction of Vascular Permeability by the Sphingosine-1-Phosphate Receptor–2 (S1P2R) and its Downstream Effectors ROCK and PTEN

  2007cited by this paper
• Critical role of ABCA1 transporter in sphingosine 1‐phosphate release from astrocytes

  2007cited by this paper
• Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.

  2007cited by this paper
• HDL-like lipoproteins in cerebrospinal fluid affect neural cell activity through lipoprotein-associated sphingosine 1-phosphate.

  2007cited by this paper
• Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.

  2007cited by this paper
• Endothelial-Dependent Mechanisms of Leukocyte Recruitment to the Vascular Wall

  2007cited by this paper
• Negative regulation of endothelial morphogenesis and angiogenesis by S1P2 receptor.

  2006cited by this paper
• Sphingosine-1 Phosphate Prevents Monocyte/Endothelial Interactions in Type 1 Diabetic NOD Mice Through Activation of the S1P1 Receptor

  2006cited by this paper
• ABCA1 and biogenesis of HDL.

  2006cited by this paper
• Role of Scavenger Receptor Class B Type I and Sphingosine 1-Phosphate Receptors in High Density Lipoprotein-induced Inhibition of Adhesion Molecule Expression in Endothelial Cells*

  2006influential reference
• High-Density Lipoproteins Enhance Progenitor-Mediated Endothelium Repair in Mice

  2006cited by this paper
• Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases.

  2006cited by this paper
• The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function.

  2006cited by this paper
• Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner Published, JLR Papers in Press, December 21, 2005.

  2006cited by this paper
• Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.

  2006cited by this paper
• PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation.

  2006cited by this paper
• Follicular Fluid High Density Lipoprotein-associated Sphingosine 1-Phosphate Is a Novel Mediator of Ovarian Angiogenesis*

  2006cited by this paper
• Transactivation of Sphingosine 1-Phosphate Receptors Is Essential for Vascular Barrier Regulation

  2006cited by this paper
• Molecular regulation of HDL metabolism and function: implications for novel therapies.

  2006influential reference
• Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient.

  2006influential reference
• Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae.

  2006cited by this paper
• Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells.

  2006influential reference
• High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P3 Lysophospholipid Receptor

  2006influential reference
• Role of ABCC1 in export of sphingosine-1-phosphate from mast cells

  2006cited by this paper
• Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR4-Dependent Signaling Pathway via the S1P3 Receptor

  2006cited by this paper
• Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.

  2006cited by this paper
• Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.

  2005cited by this paper
• Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids.

  2005cited by this paper
• ATP-binding cassette transporter AI and its role in HDL formation

  2005cited by this paper
• The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration.

  2005cited by this paper
• High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component.

  2005cited by this paper
• Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling.

  2005cited by this paper
• High-Density Lipoproteins Induce Transforming Growth Factor-&bgr;2 Expression in Endothelial Cells

  2005cited by this paper
• Sphingosine-1-Phosphate Prevents Tumor Necrosis Factor-&agr;–Mediated Monocyte Adhesion to Aortic Endothelium in Mice

  2005influential reference
• The role of sphingosine-1-phosphate in smooth muscle contraction.

  2005influential reference
• S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF.

  2005cited by this paper
• In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights.

  2005cited by this paper
• HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling.

  2004cited by this paper
• Apolipoprotein A-I Activates Cellular cAMP Signaling through the ABCA1 Transporter*

  2004cited by this paper
• Sphingosine 1-phosphate activates Weibel-Palade body exocytosis.

  2004cited by this paper
• Sphingosine 1-Phosphate Stimulates Smooth Muscle Cell Differentiation and Proliferation by Activating Separate Serum Response Factor Co-factors*

  2004cited by this paper
• High-Density Lipoprotein Stimulates Myocardial Perfusion In Vivo

  2004cited by this paper
• Sphingosine Kinase Activation Mediates Ischemic Preconditioning in Murine Heart

  2004cited by this paper
• Point-Counterpoint of Sphingosine 1-Phosphate Metabolism

  2004cited by this paper
• HDL Cholesterol and Protective Factors in Atherosclerosis

  2004cited by this paper
• Expression of adhesion molecules by sphingosine 1-phosphate and histamine in endothelial cells.

  2004cited by this paper
• High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation.

  2004cited by this paper
• Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference.

  2004cited by this paper
• Reconstituted High-Density Lipoprotein Inhibits Thrombin-Induced Endothelial Tissue Factor Expression Through Inhibition of RhoA and Stimulation of Phosphatidylinositol 3-Kinase but not Akt/Endothelial Nitric Oxide Synthase

  2004cited by this paper
• HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

  2004influential reference
• Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism.

  2004cited by this paper
• Lysophospholipid receptors: signaling and biology.

  2004influential reference
• Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury.

  2004cited by this paper
• Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages.

  2004cited by this paper
• High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells.

  2003cited by this paper
• HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner.

  2003cited by this paper
• Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2.

  2003cited by this paper
• High Density Lipoprotein–Induced Angiogenesis Requires the Activation of Ras/MAP Kinase in Human Coronary Artery Endothelial Cells

  2003cited by this paper
• High-Density Lipoprotein Stimulates Endothelial Cell Migration and Survival Through Sphingosine 1-Phosphate and Its Receptors

  2003cited by this paper
• Can Angiotensin II Type 2 Receptors Have Deleterious Effects in Cardiovascular Disease?: Implications for Therapeutic Blockade of the Renin–Angiotensin System

  2003cited by this paper
• Regulation of reverse cholesterol transport and clinical implications.

  2003cited by this paper
• Inhibitory and Stimulatory Regulation of Rac and Cell Motility by the G12/13-Rho and Gi Pathways Integrated Downstream of a Single G Protein-Coupled Sphingosine-1-Phosphate Receptor Isoform

  2003cited by this paper
• Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells.

  2003influential reference
• Sphingosine-1-phosphate: an enigmatic signalling lipid

  2003cited by this paper
• Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease.

  2003cited by this paper
• S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate.

  2003cited by this paper
• High Density Lipoprotein-induced Signaling of the MAPK Pathway Involves Scavenger Receptor Type BI-mediated Activation of Ras*

  2003cited by this paper
• Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate.

  2003cited by this paper
• Involvement of Cdc42 Signaling in ApoA-I-induced Cholesterol Efflux*

  2003cited by this paper
• PECAM-1: old friend, new partners.

  2003cited by this paper
• Ligand-dependent Inhibition of B16 Melanoma Cell Migration and Invasion via Endogenous S1P2 G Protein-coupled Receptor

  2003cited by this paper
• Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCε knockout mouse hearts

  2002cited by this paper
• HDL and arteriosclerosis: beyond reverse cholesterol transport.

  2002cited by this paper
• Involvement of Endothelial Nitric Oxide in Sphingosine‐1‐Phosphate‐Induced Angiogenesis

  2002cited by this paper
• Sphingosine-1-Phosphate, a Platelet-Derived Lysophospholipid Mediator, Negatively Regulates Cellular Rac Activity and Cell Migration in Vascular Smooth Muscle Cells

  2002cited by this paper

• Dietary obesity and glycemic excursions cause a parallel increase in STEAP4 and pro-inflammatory gene expression in murine PBMCs

  2021cites this paper
• Potential of Lipoprotein-Based Nanoparticulate Formulations for the Treatment of Eye Diseases.

  2020cites this paper
• Endurance training selectively increases high‐density lipoprotein‐bound sphingosine‐1‐phosphate in the plasma

  2018cites this paper
• S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization[S]

  2017cites this paper
• The effect of sphingosine-1-phosphate on bone metabolism in humans depends on its plasma/bone marrow gradient

  2016cites this paper
• Serum Apolipoprotein M Levels are Correlated with Biomarkers of Coagulation

  2016cites this paper
• Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis.

  2015cites this paper
• HDL-cholesterol in coronary artery disease risk: function or structure?

  2014cites this paper
• Sphingosine 1-phosphate induced anti-atherogenic and atheroprotective M2 macrophage polarization through IL-4.

  2014cites this paper
• Individual variation of human S1P1 coding sequence leads to heterogeneity in receptor function and drug interactions[S]

  2014cites this paper
• Lipoprotein-associated lysolipids are differentially involved in high-density lipoprotein- and its oxidized form-induced neurite remodeling in PC12 cells.

  2014cites this paper
• High Density Lipoprotein Stimulated Migration of Macrophages Depends on the Scavenger Receptor Class B, Type I, PDZK1 and Akt1 and Is Blocked by Sphingosine 1 Phosphate Receptor Antagonists

  2014cites this paper
• High‐density lipoprotein 3 and apolipoprotein A‐I alleviate platelet storage lesion and release of platelet extracellular vesicles

  2014cites this paper
• Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy

  2013cites this paper
• ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT[S]

  2013cites this paper
• Molecular biology of atherosclerosis.

  2013cites this paper
• HDL drug carriers for targeted therapy.

  2013cites this paper
• Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M.

  2013cites this paper
• HDL-related mechanisms of olive oil protection in cardiovascular disease.

  2012cites this paper
• Signal transduction pathways provide opportunities to enhance HDL and apoAI-dependent reverse cholesterol transport.

  2012cites this paper
• Assessment of sphingosine-1-phosphate activity in biological samples by receptor internalization and adherens junction formation.

  2012cites this paper
• Pleiotropic Functions of HDL Lead to Protection from Atherosclerosis and Other Diseases

  2012cites this paper
• Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R−/−) mice

  2012cites this paper
• Effects of Sphingosine-1-phosphate on Proliferation and Cell-surface Markers of Human Umbilical Cord Mesenchymal Stem Cells

  2012cites this paper
• Simple Lipids with Only One Component

  2012cites this paper
• Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.

  2011cites this paper
• Sphingosine 1-phosphate in coagulation and inflammation

  2011cites this paper
• Molecular Biology and Genetics of Atherosclerosis

  2011cites this paper
• Unmasking of LPA1 receptor‐mediated migration response to lysophosphatidic acid by interleukin‐1β‐induced attenuation of Rho signaling pathways in rat astrocytes

  2011cites this paper
• HDL and sphingosine‐1‐phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion

  2011cites this paper
• Exercise increases plasma levels of sphingoid base‐1 phosphates in humans

  2011cites this paper
• Negatively cooperative binding of high-density lipoprotein to the HDL receptor SR-BI.

  2011cites this paper
• Role of the SAFE pathway and the mitochondria in HDL cholesterol (and its constituent sphingosine-1-phosphate) induced cardioprotection

  2011cites this paper
• Molecular Cancer esearch aling and Regulation h-Density Lipoprotein Induces Proliferation and Migration uman Prostate Androgen – Independent Cancer Cells by R BCA 1-Dependent Mechanism

  2010cites this paper
• Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.

  2010cites this paper
• Searching for novel cardiometabolic biomarkers : method development for differential approaches and analysis of lipids involved in lipoprotein metabolism

  2010cites this paper
• A role for the scavenger receptor, class B type I in high density lipoprotein dependent activation of cellular signaling pathways.

  2010cites this paper
• High-Density Lipoprotein Induces Proliferation and Migration of Human Prostate Androgen–Independent Cancer Cells by an ABCA1-Dependent Mechanism

  2010influential citation
• Signaling pathways involved in DNA synthesis and migration in response to lysophosphatidic acid and low-density lipoprotein in coronary artery smooth muscle cells.

  2009cites this paper
• Mechanism and Role of High Density Lipoprotein-induced Activation of AMP-activated Protein Kinase in Endothelial Cells*

  2009cites this paper
• Export and functions of sphingosine-1-phosphate.

  2009cites this paper